Skip to main content

Advertisement

Emerging rare genetic and genomic syndromes in autism and developmental delay

Edited by: Professor Joseph Buxbaum (Icahn School of Medicine at Mount Sinai) and Dr Catalina Betancur (Université Pierre et Marie Curie)

Molecular Autism is accepting research manuscript submissions for consideration in a thematic series entitled Emerging rare genetic and genomic syndromes in autism and development delay

New Content ItemRare genetic and genomic syndromes have provided insights into the molecular, cellular and circuit changes that underlie autism and associated developmental delay syndromes. For example, both Fragile X and Rett syndrome have elucidated atypical biology associated with autism and have led to novel neurobiologically-based clinical trials.

With the existence of large, well-characterized sample sets and the explosion of high-throughput methods in genetics there are numerous new genetic and genomic disorders that are being identified in autism. Manuscripts focusing on preclinical and clinical empirical studies of these emerging rare disorders are welcome. The editors will also consider proposals for up-to-date review articles on relevant topics for inclusion in the thematic series.

​​​​​​​The deadline for submissions is 31 July 2017 and articles will be published continuously on acceptance.

Please submit online and indicate in your covering letter that you would like the article to be considered for this thematic series. If you have a proposal for a review article or any enquiries about the suitability or submission date of your article for this thematic series please contact editorial@molecularautism.com

For more information about Molecular Autism, please visit our website.

  1. Research

    Replicable in vivo physiological and behavioral phenotypes of the Shank3B null mutant mouse model of autism

    Autism spectrum disorder (ASD) is a clinically and biologically heterogeneous condition characterized by social, repetitive, and sensory behavioral abnormalities. No treatments are approved for the core diagno...

    Sameer C. Dhamne, Jill L. Silverman, Chloe E. Super, Stephen H. T. Lammers, Mustafa Q. Hameed, Meera E. Modi, Nycole A. Copping, Michael C. Pride, Daniel G. Smith, Alexander Rotenberg, Jacqueline N. Crawley and Mustafa Sahin

    Molecular Autism 2017 8:26

    Published on: 15 June 2017

Advertisement